Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.

Waijiao Tang Xiaorui Yao Fan XiaMiaoting YangZhijuan ChenBen-Jie Zhou Qiang Liu

Published in: Oxidative medicine and cellular longevity (2018)

In summary, the HQT has potential applications in the prevention and treatment of NAFLD, which may be closely related to its modulatory effect on the gut microbiota.

Keyphrases

high fat diet induced
metabolic syndrome
combination therapy
replacement therapy